Literature DB >> 8232952

Scrapie prions alter receptor-mediated calcium responses in cultured cells.

K Kristensson1, B Feuerstein, A Taraboulos, W C Hyun, S B Prusiner, S J DeArmond.   

Abstract

The molecular basis of neurologic dysfunction in prion diseases is unknown. Spongiform degeneration of neurons is the most characteristic neuropathologic change which raises the possibility of abnormal ion channel function. Here we examined the regulation of Ca2+ fluxes in two cell lines chronically infected with scrapie prions, designated ScN2a (scrapie-infected mouse neuroblatoma) and ScHaB (scrapie-infected hamster brain) cells. In uninfected HaB cells, bradykinin caused increases in intracellular Ca2+ concentration ([Ca2+]i) by release of Ca2+ from internal stores and influx of extracellular Ca2+ whereas, in N2a cells, bradykinin increased [Ca2+]i exclusively from internal stores. Prion infection of both cell lines markedly reduced or eliminated bradykinin-activated increases in [Ca2+]i, whether driven by internal or extracellular sources. Stressing the cells with high extracellular [Ca2+], 8 to 20 mM, led to cytopathologic changes in ScHaB but not in ScN2a cells. Cytopathology was not preceded by an increase in [Ca2+]i. These findings indicate that scrapie infection induces abnormalities in receptor-mediated Ca2+ responses and raise the possibility that nerve cell dysfunction and degeneration in prion diseases is related to ion channel aberrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232952     DOI: 10.1212/wnl.43.11.2335

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Cultured cell sublines highly susceptible to prion infection.

Authors:  P J Bosque; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis.

Authors:  H M Schätzl; L Laszlo; D M Holtzman; J Tatzelt; S J DeArmond; R I Weiner; W C Mobley; S B Prusiner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 3.  Cellular biology of prion diseases.

Authors:  D A Harris
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

4.  Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease.

Authors:  M Diez; J Koistinaho; S J Dearmond; D Groth; S B Prusiner; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Scrapie infection alters the membrane and synaptic properties of mouse hippocampal CA1 pyramidal neurones.

Authors:  A R Johnston; C Black; J Fraser; N MacLeod
Journal:  J Physiol       Date:  1997-04-01       Impact factor: 5.182

6.  Engineering a murine cell line for the stable propagation of hamster prions.

Authors:  Matthew E C Bourkas; Hamza Arshad; Zaid A M Al-Azzawi; Ondrej Halgas; Ronald A Shikiya; Mohadeseh Mehrabian; Gerold Schmitt-Ulms; Jason C Bartz; Joel C Watts
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

7.  Induction of ligand-specific PrP (C) signaling in human neuronal cells.

Authors:  Ryan J Arsenault; Yue Li; Andrew Potter; Philip J Griebel; Anthony Kusalik; Scott Napper
Journal:  Prion       Date:  2012-08-23       Impact factor: 3.931

Review 8.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

9.  Disease-associated mutations in the prion protein impair laminin-induced process outgrowth and survival.

Authors:  Cleiton F Machado; Flavio H Beraldo; Tiago G Santos; Dominique Bourgeon; Michele C Landemberger; Martin Roffé; Vilma R Martins
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

Review 10.  Astrocyte signaling and neurodegeneration: new insights into CNS disorders.

Authors:  Liliana Brambilla; Francesca Martorana; Daniela Rossi
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.